Keyphrases
Denmark
100%
National Cohort Study
100%
Cutaneous T-cell Lymphoma
100%
Total Skin Electron Beam Therapy (TSEBT)
100%
High Dose
55%
Median Time
44%
Progressive Disease
22%
Complete Response
22%
Complete Response Rate
22%
Clinical Response
11%
Response to Treatment
11%
Treatment Response
11%
Palliation
11%
Initial Treatment
11%
Low-dose Treatment
11%
Curative Treatment
11%
Progression-free Survival
11%
Lack of Response
11%
Systemic Treatment
11%
Relapse-free Survival
11%
Therapy Treatment
11%
Skin-directed Treatment
11%
Low-dose Therapy
11%
Palliative Treatment
11%
Overall Response Rate
11%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Cutaneous T Cell Lymphoma
100%
Disease
80%
Side Effect
20%
Retrospective Study
20%
Progression Free Survival
20%
Systemic Treatment
20%
Recurrence Free Survival
20%